Cypher AI
4 known investors
Find your way into Cypher AI
Sign up to see every warm intro you have to Cypher AI
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cypher AI team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cypher is an AI-native ELN and LIMS platform for life-sciences R&D teams, letting scientists record experiments, track samples with lineage, run analyses and bioinformatics pipelines, and order outside lab work, with an AI agent that operates on their own data. It serves drug discovery, synthetic biology, analytical chemistry and other R&D groups, offering cloud deployment with data residency in the US, EU or China.
Investors · 4
Connecticut Innovationslisted by Connecticut InnovationsNew Haven · $500K – $2M
How we know: Connecticut Innovations's portfolio page · Not right? Tell us
Fifty Yearslisted by Fifty YearsSan Francisco · $250K – $2M
How we know: Fifty Years's portfolio page · Not right? Tell us
Frequently asked questions
- What does Cypher AI do?
- Cypher is an AI-native ELN and LIMS platform for life-sciences R&D teams, letting scientists record experiments, track samples with lineage, run analyses and bioinformatics pipelines, and order outside lab work, with an AI agent that operates on their own data. It serves drug discovery, synthetic biology, analytical chemistry and other R&D groups, offering cloud deployment with data residency in the US, EU or China.
- Who are Cypher AI's investors?
- Cypher AI's investors include Connecticut Innovations, Fifty Years, MaC Venture Capital, Sparta Group.